SCHEMBL20061786

SCHEMBL20061786

c1ccc2c(c1)C1c3cnccc3C2c2ncncc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP11B2 P19099 1/20 0.33
EGFR P00533 1/20 0.32
HSP90AA1 P07900 1/20 0.31
ADRA1D P25100 2/20 0.31
ADRA1A P35348 2/20 0.31
CYP1A2 P05177 2/20 0.31
ALOX15 P16050 2/20 0.31
HSD17B10 Q99714 2/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HIF1A Q16665 1/20 0.31
ADRA2A P08913 1/20 0.30
ADRA1B P35368 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
HTR3E A5X5Y0 1/20 0.30
HTR3B O95264 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20061807 1.00 CYP2A6 (0.33) CYP2A6L3MBTL1CYP11B2EGFRHSP90AA1
SCHEMBL20061784 0.91 EGFR (0.38) CYP2A6EGFRADRA1DADRA1AALOX15
SCHEMBL20061818 0.89 MAPK9 (0.37) CYP2A6CYP11B2EGFRALDH1A1
SCHEMBL20061791 0.89 MAPK9 (0.37) CYP2A6CYP11B2EGFRALDH1A1
SCHEMBL20061797 0.84 CYP2A6 (0.34) CYP2A6L3MBTL1CYP11B2EGFRADRA1D
SCHEMBL20061785 0.83 L3MBTL1 (0.38) CYP2A6L3MBTL1HSP90AA1CYP1A2ALOX15
SCHEMBL20061811 0.83 CYP2A6 (0.33) CYP2A6L3MBTL1CYP11B2EGFRADRA1D
SCHEMBL20061803 0.82 HSP90AA1 (0.37) L3MBTL1HSP90AA1ADRA1DADRA1AALDH1A1
SCHEMBL20061789 0.81 KDM4E (0.40) CYP2A6CYP11B2EGFRCYP1A2ALDH1A1
SCHEMBL20061800 0.81 KDM4E (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11239432-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-02-01 US disclosed
US-20180108848-A1 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-04-19 US disclosed
US-20180108848-A1 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11239432-B2 Organic electroluminescent materials and devices OCIAD1, OSBP, OCIAD2 CYP2A6 2512/4885L3MBTL1 2032/4885CYP11B2 406/4885
US-20180108848-A1 Organic electroluminescent materials and devices OSBP, OSBP2, OCIAD2 CYP2A6 3830/4885L3MBTL1 1467/4885CYP11B2 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.